Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah E Baxley

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Drug Targets|June 16, 2010
Inhibiting breast cancer progression by exploiting TGFbeta signalingSarah E Baxley, Rosa Serra
Biology of Reproduction|July 15, 2011
Misexpression of wingless-related MMTV integration site 5A in mouse mammary gland inhibits the milk ejection response and regulates connexin43 phosphorylationSarah E Baxley, Wen Jiang, Rosa Serra
Journal of Women'S Health (2002)|February 10, 2025
Improving Access to Expanded Genetic Carrier Screening Through Multimodal InterventionsLauren N Meiss, Shefali Pathy, Sarah E Baxley
Journal of Mammary Gland Biology and Neoplasia|March 19, 2011
Wnt5a as an effector of TGFβ in mammary development and cancerRosa Serra, Stephanie L Easter, Wen Jiang, et al.
Breast Cancer Research : BCR|April 7, 2009
Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotypeKevin Roarty, Sarah E Baxley, Michael R Crowley, et al.
Plos One|November 18, 2014
Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumorsStephanie L Easter, Elizabeth H Mitchell, Sarah E Baxley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Drug Targets|June 16, 2010
Inhibiting breast cancer progression by exploiting TGFbeta signalingSarah E Baxley, Rosa Serra
Biology of Reproduction|July 15, 2011
Misexpression of wingless-related MMTV integration site 5A in mouse mammary gland inhibits the milk ejection response and regulates connexin43 phosphorylationSarah E Baxley, Wen Jiang, Rosa Serra
Journal of Women'S Health (2002)|February 10, 2025
Improving Access to Expanded Genetic Carrier Screening Through Multimodal InterventionsLauren N Meiss, Shefali Pathy, Sarah E Baxley
Journal of Mammary Gland Biology and Neoplasia|March 19, 2011
Wnt5a as an effector of TGFβ in mammary development and cancerRosa Serra, Stephanie L Easter, Wen Jiang, et al.
Breast Cancer Research : BCR|April 7, 2009
Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotypeKevin Roarty, Sarah E Baxley, Michael R Crowley, et al.
Plos One|November 18, 2014
Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumorsStephanie L Easter, Elizabeth H Mitchell, Sarah E Baxley, et al.
Pageof 1